Skip to content
Trending storyDeveloping

Open multimodal resource maps 1,000 colorectal cancers by proteomics and histology

1 report1 sourceupdated 19 hours ago

Start here

Synthesis

A research team has released a clinically annotated, open-access resource covering 1,000 treatment-naive colorectal cancers. It integrates deep proteomics, targeted genomics, whole-slide histopathology and clinical follow-up data. Analysis of the proteome defined six subgroups and split the chromosomally unstable class into three functional subgroups, one indolent with favorable prognosis and one rare, previously unrecognized subgroup with poor prognosis. The resource, posted as a preprint, is available for the community to mine for biomarker and stratification work. Questions that remain open include independent validation of the newly defined subgroups and how the proteomic classification will translate into treatment decisions.

Written by a model from the reports · updated 5 hours ago

Coverage timeline

Follow the coverage to see the different angles.

Oct 21
  1. bioRxivPick
    A clinically annotated proteomic and histological resource of 1,000 colorectal cancers

    A research team has released a multimodal open resource covering 1,000 treatment-naive colorectal cancers, integrating deep proteomics, targeted genomics, whole-slide histopathology and clinical follow-up. From the proteome they define six subgroups and resolve the chromosomally unstable class into three functional subgroups, including an indolent subgroup with favorable prognosis and a rare, previously unrecognized subgroup with adverse outcome.

Coverage and heat for this story

Reports so far 1·Heat now 6·Peak heat 10 (Oct 21 08:00)·Reports, 24h +1

Cumulative reports
00.51
Heat index (decays)
0510Oct21Oct21Oct21Oct22

Two panels, same clock (pointer stays in sync): top is cumulative editorial reports — only rises; last point = All reports; slope = new reports that hour. Bottom is Live-board heatIndex — 7-day participants with a 24-hour half-life, so it can fall when talk cools.

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org